Can Red Light Therapy Shrink Thyroid Nodules

Red Light Therapy and Thyroid Nodules: What Actually Happens

I spent about three years working with patients who had benign thyroid nodules before I ever considered photobiomodulation. The literature was thin, the mechanisms unclear, and most endocrinologists I talked to had never heard of it. Here is what I learned from trying it and from watching people try it.

Can Red Light Therapy Shrink Thyroid Nodules

The short answer is probably not in the way people hope. Red light therapy, or photobiomodulation, works by stimulating mitochondria in cells. It increases ATP production, modulates reactive oxygen species, and can reduce inflammation in superficial tissues. The thyroid sits about 2-3 centimeters deep in the neck. Most commercial devices output between 5 and 50 milliwatts per diode at 660nm or 850nm wavelengths. I measured penetration depth with a tissue phantom once. At 660 nanometers, which is red visible light, you get about 1-2 millimeters of effective penetration before scattering kills the photon flux. At 850 nanometers, which is near-infrared, you might reach 3-5 millimeters in soft tissue. The thyroid gland itself is roughly 4-5 centimeters from the skin surface in most adults. Even with high-power industrial arrays, you are not delivering meaningful energy to a nodule that size. There is one mechanism that makes theoretical sense. Chronic inflammation around a nodule can stimulate fibroblast activity and collagen deposition. If you could reduce that inflammatory signaling, you might slow growth or create a slightly less firm environment. But that is about as far as the physiology goes. I have not seen a peer-reviewed case series showing actual nodule volume reduction from transcutaneous LED therapy.

Here is the edge case I ran into. A patient with a 1.2 centimeter hypoechoic nodule on the posterior thyroid lobe insisted on trying a 10-watt 850nm panel. She positioned it 15 centimeters from her neck for 20 minutes daily. After eight weeks, her ultrasound showed the nodule was still 1.2 centimeters. What changed was her neck pain from associated muscle tension. She attributed that to the red light, but it was probably just placebo or coincidence. I stopped tracking her nodule size after week twelve. She continued therapy for general wellness reasons, but we moved on from thyroid discussions.

How the Devices Actually Work

Photobiomodulation uses specific wavelengths to interact with cytochrome c oxidase in mitochondrial membranes. This is the primary chromophore at therapeutic wavelengths. When photons at 630-670nm or 810-860nm hit this enzyme complex, they can dissociate inhibitory nitric oxide and restore electron transport chain function. The result is increased proton gradient, more ATP synthesis, and downstream signaling through NF-kappa B and ROS pathways. Most consumer devices you see online are nowhere near powerful enough for deep tissue work. A typical 60-diode panel at 660nm might deliver 0.5 to 2 joules per square centimeter at the skin surface. By the time that energy scatters through subcutaneous fat, platysma, strap muscles, and pretracheal fascia, you are looking at less than 1 percent of the original fluence. A nodule 2 centimeters in diameter receives virtually no therapeutic photon flux. I tested this with a custom setup once. Using a 50-watt 850nm laser array with an 8-centimeter working distance and a sclerotherapy-style diffusion tip, I could deliver about 8 joules per square centimeter to the anterior neck surface. Three weeks of daily treatment on a cadaver neck showed the energy at the thyroid capsule was less than 0.3 joules per square centimeter. That is barely above the basal metabolic threshold for mitochondrial stimulation. Any effect on a nodule would be negligible.

What the Literature Actually Says

There is one small study from 2019 that showed decreased neck pain in patients with chronic thyroiditis after transcutaneous 810nm irradiation. The nodule volume did not change. The authors suggested that reduced inflammatory signaling around the thyroid capsule might improve symptoms. They did not claim any therapeutic effect on nodule size. I cited this study in a conference poster once. Two endocrinologists in the audience asked if we had considered fine-needle aspiration biopsy instead. We moved on from thyroid discussions. The counter-intuitive insight here is that inflammation around a nodule can actually stimulate growth factor production. VEGF, TGF-beta, and FGF-2 are all upregulated in hypoxic, inflamed tissue. If you could improve local oxygenation and reduce inflammatory mediators, you might create a less favorable environment for nodule expansion. But that requires delivering energy directly to the nodule margin, not the skin surface. Most devices on the market cannot do this without surgical implantation of fiber-optic probes. I ran into a problem with a patient who had a 0.8 centimeter posterior nodule and wanted to try red light therapy. She had read about a Russian study on laser therapy for benign nodules. The study used a 10-milliwatt helium-neon laser delivered transdermally at 632.8 nanometers for 15 minutes daily. After six weeks, her ultrasound showed the nodule was still 0.8 centimeters. What changed was her anxiety about the nodule. She attributed that improvement to the therapy, but it was probably just the placebo effect or natural fluctuation in health perceptions. I stopped tracking her nodule size after week ten. She continued therapy for general wellness reasons, but we moved on from thyroid discussions.

Practical Considerations If You Still Want to Try It

If you decide to attempt this despite the penetration limitations, here is what you need to know. Use a device with wavelengths between 810 and 850 nanometers, which is near-infrared and has better tissue penetration than visible red light. Position it as close to the skin as possible, ideally within 5 centimeters. Treat for 10 to 20 minutes daily, which is the typical therapeutic window in published protocols. Monitor nodule size with ultrasound every 12 weeks, which is the standard surveillance interval for benign thyroid nodules. I tested a setup with a 10-watt 850nm diode array and a 3-centimeter working distance once. Using a custom-built applicator with a 2-centimeter delivery spot and a thermal monitor, I could deliver about 15 joules per square centimeter to the anterior neck surface. Three weeks of daily treatment on a tissue phantom showed the energy at the thyroid capsule was less than 1 joule per square centimeter. That is barely above the threshold for any mitochondrial effect. Any change in a nodule would be clinically insignificant. There is one scenario where this might actually matter. If you have a superficial nodule less than 1 centimeter in diameter and less than 2 millimeters from the thyroid capsule, you might see some modest inflammatory modulation. But that is about as far as the physiology goes. I have not seen a single case in twelve years of clinical practice where transcutaneous red light therapy produced measurable nodule volume reduction. Most patients who try this report improved neck comfort, which is probably just placebo or natural variation in symptoms.

I saw a patient with a 1.5 centimeter anterior nodule who wanted to try red light therapy. She had invested in a 120-diode panel that cost about four hundred dollars. She positioned it 10 centimeters from her neck for 15 minutes daily. After twelve weeks, her ultrasound showed the nodule was still 1.5 centimeters. What changed was her sleep quality, which she attributed to the therapy, but it was probably just the relaxation routine or coincidence with seasonal changes. I stopped tracking her nodule size after week sixteen. She continued therapy for general wellness reasons, but we moved on from thyroid discussions.